Literature DB >> 33961312

Pulseq-CEST: Towards multi-site multi-vendor compatibility and reproducibility of CEST experiments using an open-source sequence standard.

Kai Herz1,2, Sebastian Mueller1,2, Or Perlman3, Maxim Zaitsev4, Linda Knutsson5,6, Phillip Zhe Sun7, Jinyuan Zhou6, Peter van Zijl6,8, Kerstin Heinecke9, Patrick Schuenke9, Christian T Farrar3, Manuel Schmidt10, Arnd Dörfler10, Klaus Scheffler1,2, Moritz Zaiss1,10.   

Abstract

PURPOSE: As the field of CEST grows, various novel preparation periods using different parameters are being introduced. At the same time, large, multisite clinical studies require clearly defined protocols, especially across different vendors. Here, we propose a CEST definition standard using the open Pulseq format for a shareable, simple, and exact definition of CEST protocols.
METHODS: We present the benefits of such a standard in three ways: (1) an open database on GitHub, where fully defined, human-readable CEST protocols can be shared; (2) an open-source Bloch-McConnell simulation to test and optimize CEST preparation periods in silico; and (3) a hybrid MR sequence that plays out the CEST preparation period and can be combined with any existing readout module.
RESULTS: The exact definition of the CEST preparation period, in combination with the flexible simulation, leads to a good match between simulations and measurements. The standard allowed finding consensus on three amide proton transfer-weighted protocols that could be compared in healthy subjects and a tumor patient. In addition, we could show coherent multisite results for a sophisticated CEST method, highlighting the benefits regarding protocol sharing and reproducibility.
CONCLUSION: With Pulseq-CEST, we provide a straightforward approach to standardize, share, simulate, and measure different CEST preparation schemes, which are inherently completely defined.
© 2021 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  CEST; Pulseq; open-source; standardization

Mesh:

Substances:

Year:  2021        PMID: 33961312      PMCID: PMC9149651          DOI: 10.1002/mrm.28825

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   3.737


  45 in total

1.  T1ρ-based dynamic glucose-enhanced (DGEρ) MRI at 3 T: method development and early clinical experience in the human brain.

Authors:  Kai Herz; Tobias Lindig; Anagha Deshmane; Jens Schittenhelm; Marco Skardelly; Benjamin Bender; Ulrike Ernemann; Klaus Scheffler; Moritz Zaiss
Journal:  Magn Reson Med       Date:  2019-06-23       Impact factor: 4.668

2.  DeepCEST: 9.4 T Chemical exchange saturation transfer MRI contrast predicted from 3 T data - a proof of concept study.

Authors:  Moritz Zaiss; Anagha Deshmane; Mark Schuppert; Kai Herz; Felix Glang; Philipp Ehses; Tobias Lindig; Benjamin Bender; Ulrike Ernemann; Klaus Scheffler
Journal:  Magn Reson Med       Date:  2019-02-25       Impact factor: 4.668

3.  Whole-brain snapshot CEST imaging at 7 T using 3D-EPI.

Authors:  Suzan Akbey; Philipp Ehses; Rüdiger Stirnberg; Moritz Zaiss; Tony Stöcker
Journal:  Magn Reson Med       Date:  2019-06-14       Impact factor: 4.668

4.  CEST imaging at 9.4 T using adjusted adiabatic spin-lock pulses for on- and off-resonant T1⍴-dominated Z-spectrum acquisition.

Authors:  Kai Herz; Chirayu Gandhi; Mark Schuppert; Anagha Deshmane; Klaus Scheffler; Moritz Zaiss
Journal:  Magn Reson Med       Date:  2018-09-08       Impact factor: 4.668

5.  A deep learning approach for magnetization transfer contrast MR fingerprinting and chemical exchange saturation transfer imaging.

Authors:  Byungjai Kim; Michael Schär; HyunWook Park; Hye-Young Heo
Journal:  Neuroimage       Date:  2020-07-15       Impact factor: 6.556

6.  TOPPE: A framework for rapid prototyping of MR pulse sequences.

Authors:  Jon-Fredrik Nielsen; Douglas C Noll
Journal:  Magn Reson Med       Date:  2017-11-02       Impact factor: 4.668

7.  Optimizing pulsed-chemical exchange saturation transfer imaging sequences.

Authors:  Zhongliang Zu; Ke Li; Vaibhav A Janve; Mark D Does; Daniel F Gochberg
Journal:  Magn Reson Med       Date:  2011-03-22       Impact factor: 4.668

8.  Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer.

Authors:  Kannie W Y Chan; Michael T McMahon; Yoshinori Kato; Guanshu Liu; Jeff W M Bulte; Zaver M Bhujwalla; Dmitri Artemov; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2012-10-16       Impact factor: 4.668

9.  Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.

Authors:  Osamu Togao; Takashi Yoshiura; Jochen Keupp; Akio Hiwatashi; Koji Yamashita; Kazufumi Kikuchi; Yuriko Suzuki; Satoshi O Suzuki; Toru Iwaki; Nobuhiro Hata; Masahiro Mizoguchi; Koji Yoshimoto; Koji Sagiyama; Masaya Takahashi; Hiroshi Honda
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

Review 10.  APT-weighted MRI: Techniques, current neuro applications, and challenging issues.

Authors:  Jinyuan Zhou; Hye-Young Heo; Linda Knutsson; Peter C M van Zijl; Shanshan Jiang
Journal:  J Magn Reson Imaging       Date:  2019-01-20       Impact factor: 4.813

View more
  6 in total

Review 1.  Molecular Imaging of Brain Tumors and Drug Delivery Using CEST MRI: Promises and Challenges.

Authors:  Jianpan Huang; Zilin Chen; Se-Weon Park; Joseph H C Lai; Kannie W Y Chan
Journal:  Pharmaceutics       Date:  2022-02-20       Impact factor: 6.321

2.  The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T.

Authors:  Julia P Lingl; Arthur Wunderlich; Steffen Goerke; Daniel Paech; Mark E Ladd; Patrick Liebig; Andrej Pala; Soung Yung Kim; Michael Braun; Bernd L Schmitz; Meinrad Beer; Johannes Rosskopf
Journal:  Diagnostics (Basel)       Date:  2022-02-14

Review 3.  The potential of advanced MR techniques for precision radiotherapy of glioblastoma.

Authors:  Patrick L Y Tang; Alejandra Méndez Romero; Jaap P M Jaspers; Esther A H Warnert
Journal:  MAGMA       Date:  2022-02-07       Impact factor: 2.310

Review 4.  High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics.

Authors:  Thomas C Booth; Evita C Wiegers; Esther A H Warnert; Kathleen M Schmainda; Frank Riemer; Ruben E Nechifor; Vera C Keil; Gilbert Hangel; Patrícia Figueiredo; Maria Del Mar Álvarez-Torres; Otto M Henriksen
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 5.738

Review 5.  Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.

Authors:  Jinyuan Zhou; Moritz Zaiss; Linda Knutsson; Phillip Zhe Sun; Sung Soo Ahn; Silvio Aime; Peter Bachert; Jaishri O Blakeley; Kejia Cai; Michael A Chappell; Min Chen; Daniel F Gochberg; Steffen Goerke; Hye-Young Heo; Shanshan Jiang; Tao Jin; Seong-Gi Kim; John Laterra; Daniel Paech; Mark D Pagel; Ji Eun Park; Ravinder Reddy; Akihiko Sakata; Sabine Sartoretti-Schefer; A Dean Sherry; Seth A Smith; Greg J Stanisz; Pia C Sundgren; Osamu Togao; Moriel Vandsburger; Zhibo Wen; Yin Wu; Yi Zhang; Wenzhen Zhu; Zhongliang Zu; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2022-04-22       Impact factor: 3.737

6.  An end-to-end AI-based framework for automated discovery of rapid CEST/MT MRI acquisition protocols and molecular parameter quantification (AutoCEST).

Authors:  Or Perlman; Bo Zhu; Moritz Zaiss; Matthew S Rosen; Christian T Farrar
Journal:  Magn Reson Med       Date:  2022-01-28       Impact factor: 3.737

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.